By IQT News posted 14 Jun 2019

(EU-Startups.com) Riverlane has raised has raised €3.7 million in seed funding for developing advanced quantum computing software, which it plans to use as a simulation engine for microscopic systems to replace laboratory tests in areas such as drug discovery. The funding was led by venture capital investors Cambridge Innovation Capital and Amadeus Capital Partners, with the participation of Cambridge Enterprise.
Riverlane’s software leverages the capabilities of the quantum computer, which operates using the principles of quantum mechanics. In the same way that graphics processing units (GPUs) accelerate machine learning workloads, Riverlane uses quantum computers to accelerate the simulation of quantum systems.
The company is working with leading academics and companies on critical early use cases for its software, such as developing new battery materials and drug treatments. Riverlane will use its seed funding to demonstrate its technology across a range of quantum computing hardware platforms, focused on early adopters in materials design and drug discovery. It will also expand its team of quantum software researchers and computational physicists.

Subscribe to Our Email Newsletter

Stay up-to-date on all the latest news from the Quantum Technology industry and receive information and offers from third party vendors.

  • Forthcoming Events

    • IQT Fall | November 1-5, 2021
      Online & In-Person New York City
    • IQT, The Hague, The Netherlands | February 21-23, 2022
    • IQT Spring | May 10-12, 2022
      Online & In-Person San Diego
    • IQT Asia-Pacific Singapore 2022 | Dates Forthcoming
    • For additional information: info@3drholdings.com
0